Title: HC Wainwright Reaffirms Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)
Author: MarketBeat News
Source: newsapi
Published: 2024-12-15T07:41:01Z
URL: https://www.etfdailynews.com/2024/12/15/hc-wainwright-reaffirms-buy-rating-for-praxis-precision-medicines-nasdaqprax/
----------------------------------------
HC Wainwright reaffirmed their buy rating on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a report released on Thursday,Benzinga reports. HC Wainwright currently has a $120.00 … [+5477 chars]